Ginkgo Bioworks (DNA): Rethinking Valuation After New University Collaboration in ARPA-H MIGHTY Oral Health Initiative [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
This partnership marks a new chapter in the company's efforts to advance oral health therapies through the ARPA-H funded MIGHTY initiative. See our latest analysis for Ginkgo Bioworks Holdings. Momentum has been hard to hold onto for Ginkgo Bioworks Holdings, with its share price down nearly 41% over the last month despite the headline-grabbing announcement of its MIGHTY partnership. However, the stock's 21% total shareholder return over the past year hints that investors still see growth potential in its expanding biotech pipeline, even after a sharp multiyear decline and some shakier recent trading. If you want to uncover more tomorrow's innovators in biotech and beyond, this is your chance to spot them early by checking out See the full list for free. With shares still trading about 36% below analyst price targets even after recent losses, the question for investors now is whether Ginkgo Bioworks is truly undervalued or if the market is already factoring in its future poten
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PCPR Newswire
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene TherapyPR Newswire
- Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks: Scaling Science, Not Revenue [Seeking Alpha]Seeking Alpha
- Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/6/25 - Miss
DNA
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 144
- 11/6/25 - Form 10-Q
- DNA's page on the SEC website